| Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma M Garnelo, A Tan, Z Her, J Yeong, CJ Lim, J Chen, KH Lim, A Weber, ... Gut 66 (2), 342-351, 2017 | 380 | 2017 |
| Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma V Chew, J Chen, D Lee, E Loh, J Lee, KH Lim, A Weber, K Slankamenac, ... Gut 61 (3), 427-438, 2012 | 355 | 2012 |
| Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients V Chew, C Tow, M Teo, HL Wong, J Chan, A Gehring, M Loh, A Bolze, ... Journal of hepatology 52 (3), 370-379, 2010 | 294 | 2010 |
| Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma CJ Lim, YH Lee, L Pan, L Lai, C Chua, M Wasser, TKH Lim, J Yeong, ... Gut 68 (5), 916-927, 2019 | 226 | 2019 |
| Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses V Chew, L Lai, L Pan, CJ Lim, J Li, R Ong, C Chua, JY Leong, KH Lim, ... Proceedings of the National Academy of Sciences 114 (29), E5900-E5909, 2017 | 191 | 2017 |
| Immune microenvironment in tumor progression: characteristics and challenges for therapy V Chew, HC Toh, JP Abastado Journal of oncology 2012, 2012 | 179 | 2012 |
| PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity TS Lim, V Chew, JL Sieow, S Goh, JPS Yeong, AL Soon, ... Oncoimmunology 5 (3), e1085146, 2016 | 163 | 2016 |
| Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma V Chew, YH Lee, L Pan, NJM Nasir, CJ Lim, C Chua, L Lai, SN Hazirah, ... Gut 68 (2), 335-346, 2019 | 155 | 2019 |
| Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model EA Bard-Chapeau, AT Nguyen, AG Rust, A Sayadi, P Lee, BQ Chua, ... Nature genetics 46 (1), 24-32, 2014 | 118 | 2014 |
| Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients V Chew, C Tow, C Huang, E Bard-Chapeau, NG Copeland, NA Jenkins, ... JNCI: Journal of the National Cancer Institute 104 (23), 1796-1807, 2012 | 99 | 2012 |
| Combinational immunotherapy for hepatocellular carcinoma: radiotherapy, immune checkpoint blockade and beyond YH Lee, D Tai, C Yip, SP Choo, V Chew Frontiers in immunology 11, 568759, 2020 | 83 | 2020 |
| Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma PHD Nguyen, S Ma, CZJ Phua, NA Kaya, HLH Lai, CJ Lim, JQ Lim, ... Nature communications 12 (1), 227, 2021 | 75 | 2021 |
| TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression V Ho, TS Lim, J Lee, J Steinberg, R Szmyd, M Tham, J Yaligar, P Kaldis, ... Oncotarget 6 (29), 27252, 2015 | 73 | 2015 |
| Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma HHM Ng, RY Lee, S Goh, ISY Tay, X Lim, B Lee, V Chew, H Li, B Tan, ... Journal for immunotherapy of cancer 8 (2), 2020 | 70 | 2020 |
| An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic use JCT Lim, JPS Yeong, CJ Lim, CCH Ong, SC Wong, VSP Chew, ... Pathology 50 (3), 333-341, 2018 | 66 | 2018 |
| Expression of CD38 on macrophages predicts improved prognosis in hepatocellular carcinoma JH Lam, HHM Ng, CJ Lim, XN Sim, F Malavasi, H Li, JJH Loh, K Sabai, ... Frontiers in immunology, 2093, 2019 | 52 | 2019 |
| Hypoxia‐driven immunosuppression by Treg and type‐2 conventional dendritic cells in HCC S Suthen, CJ Lim, PHD Nguyen, CA Dutertre, HLH Lai, M Wasser, ... Hepatology 76 (5), 1329-1344, 2022 | 48 | 2022 |
| High-dimensional immune-profiling in cancer: implications for immunotherapy S Chuah, V Chew Journal for immunotherapy of cancer 8 (1), 2020 | 46 | 2020 |
| Leupaxin negatively regulates B cell receptor signaling V Chew, KP Lam Journal of Biological Chemistry 282 (37), 27181-27191, 2007 | 36 | 2007 |
| Rationale of immunotherapy in hepatocellular carcinoma and its potential biomarkers D Tai, SP Choo, V Chew Cancers 11 (12), 1926, 2019 | 30 | 2019 |
